VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer.

Autores de IIS La Fe

• Tania Carolina Fleitas Kanonnikoff

  Autor

• Vicenta Martinez Sales

  Autor

• Virtudes Vila Liante

  Autor

• Edelmiro Reganon Salvador

  Autor

• David Mesado Espin

  Autor

• 

  José Gómez Codina

  Autor

• Joaquin Montalar Salcedo

  Autor

• Gaspar Reynes Muntaner

  Autor

Participantes ajenos a IIS La Fe

• Martín M

Grupos

• Hemostasia, Trombosis, Arteriosclerosis y Biología vascular

• Investigación Clínica y Traslacional en Cáncer

Abstract

There is a need for biomarkers that may help in selecting the most effective anticancer treatments for each patient. We have investigated the prognostic value of a set of angiogenesis, inflammation and coagulation markers in patients treated for advanced non-small cell lung cancer.